MAP2K7 and ovarian carcinoma: In ovarian cancer, LINC00852 acts as the ceRNA of miR-140-3p to promote AGTR1 expression and activate the MEK/ERK/STAT3 pathway, thereby promoting the proliferation and invasion of ovarian cancer cells [17].